Lars Dyrskjøt
@dyrskjot.bsky.social
Professor of Molecular Medicine, Aarhus University | Vice director DCCC ctDNA center | Vice President, IBCN | EAU Scientific Congress Office | GU cancers, bioinformatics, biomarkers, liquid biopsies
Reposted by Lars Dyrskjøt
Can mpMRI replace TURBT for faster treatment in MIBC?
A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #Oncology @oncoalert.bsky.social
ascopubs.org/doi/10.1200/JC…
A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #Oncology @oncoalert.bsky.social
ascopubs.org/doi/10.1200/JC…
January 15, 2025 at 8:25 PM
Can mpMRI replace TURBT for faster treatment in MIBC?
A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #Oncology @oncoalert.bsky.social
ascopubs.org/doi/10.1200/JC…
A randomized study shows that the mpMRI-first approach reduced the time to treatment by 45 days (53 vs. 98 days). No harm to non-MIBC patients. A game-changer for staging? #Oncology @oncoalert.bsky.social
ascopubs.org/doi/10.1200/JC…
I am excited to share our latest publication in Nature Genetics @naturegenet.bsky.social, marking a significant milestone in the UROMOL project—a 15+ year collaborative effort to characterize the biology of early-stage bladder cancer.
📖 Read the Full Study Here:
www.nature.com/articles/s41...
📖 Read the Full Study Here:
www.nature.com/articles/s41...
Comprehensive genomic characterization of early-stage bladder cancer - Nature Genetics
A genomic and transcriptomic analysis of nonmuscle-invasive bladder cancer identifies four molecular subtypes, and associates whole-genome duplication and immune exhaustion with tumor progression.
www.nature.com
January 3, 2025 at 10:45 AM
I am excited to share our latest publication in Nature Genetics @naturegenet.bsky.social, marking a significant milestone in the UROMOL project—a 15+ year collaborative effort to characterize the biology of early-stage bladder cancer.
📖 Read the Full Study Here:
www.nature.com/articles/s41...
📖 Read the Full Study Here:
www.nature.com/articles/s41...
Excited to share the release of a new book on bladder cancer that I had the pleasure of editing together with Margaret Knowles, featuring contributions from multiple expert authors!
December 17, 2024 at 7:53 PM
Excited to share the release of a new book on bladder cancer that I had the pleasure of editing together with Margaret Knowles, featuring contributions from multiple expert authors!
Reposted by Lars Dyrskjøt
What were the most inspiring 2024 discoveries in cancer?
Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said
aacrjournals.org/cancerdiscov...
Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said
aacrjournals.org/cancerdiscov...
December 3, 2024 at 3:46 PM
What were the most inspiring 2024 discoveries in cancer?
Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said
aacrjournals.org/cancerdiscov...
Cancer Discovery asked me, Katherine Aird, Aadel Chaudhuri, Jennifer Guerriero, Shiri Gur-Cohen, Benjamin Izar, Brittany Jenkins, Delphine Merino, Alejo Rodriguez-Fraticelli & Shensi Shen, & here's what we said
aacrjournals.org/cancerdiscov...
Reposted by Lars Dyrskjøt
Matt Galsky and ctDNA biomarker discovery. @dyrskjot.bsky.social #TOMBOLA.
December 3, 2024 at 8:58 PM
Matt Galsky and ctDNA biomarker discovery. @dyrskjot.bsky.social #TOMBOLA.
Reposted by Lars Dyrskjøt
‘A place of joy’: why scientists are joining the rush to Bluesky
‘A place of joy’: why scientists are joining the rush to Bluesky
Researchers say the social-media platform — an alternative to X — offers more control over the content they see and the people they engage with.
www.nature.com
November 22, 2024 at 10:09 AM
‘A place of joy’: why scientists are joining the rush to Bluesky